J. Atherton

P2Y1 receptor antagonists as novel antithrombotic agents.

G. Lu, J. Pfefferkorn, M. Leininger, 2008, Bioorganic & medicinal chemistry letters.

Optimization of 5-vinylaryl-3-pyridinecarbonitriles as PKCtheta inhibitors.

D. Boschelli, Biqi Wu, Xiaoke Yang, 2010, Bioorganic & medicinal chemistry letters.

A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif.

G. S. Walker, A. Kalgutkar, A. Mutlib, 2007, Chemical research in toxicology.

Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone.

A. Kalgutkar, S. Strom, A. Mutlib, 2006, Toxicological sciences : an official journal of the Society of Toxicology.

Biotransformation: Impact and Application of Metabolism in Drug Discovery.

S. Wrigley, J. Atherton, J. Boer, 2020, ACS medicinal chemistry letters.

Development and application of sensitive HPLC assays for NK3 antagonists in rat plasma.

J. Atherton, B. Kuo, 1998, Journal of pharmaceutical and biomedical analysis.

Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone.

A. Kalgutkar, S. Strom, A. Mutlib, 2006, Toxicological sciences : an official journal of the Society of Toxicology.